155 related articles for article (PubMed ID: 32205607)
1. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Be Flat Dose.
Co I; Hyzy RC
Crit Care Med; 2020 Apr; 48(4):591-593. PubMed ID: 32205607
[No Abstract] [Full Text] [Related]
2. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Not Be Flat Dose.
Flannery AH; Moss M
Crit Care Med; 2020 Apr; 48(4):588-590. PubMed ID: 32205606
[No Abstract] [Full Text] [Related]
3. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
Huang DT; Angus DC; Moss M; Thompson BT; Ferguson ND; Ginde A; Gong MN; Gundel S; Hayden DL; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Liu KD; Talmor DS; Yealy DM;
Ann Am Thorac Soc; 2017 Jan; 14(1):124-133. PubMed ID: 27779896
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
deBacker J; Hart N; Fan E
Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
[TBL] [Abstract][Full Text] [Related]
6. Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network.
Wongtangman K; Grabitz SD; Hammer M; Wachtendorf LJ; Xu X; Schaefer MS; Fassbender P; Santer P; Kassis EB; Talmor D; Eikermann M;
Crit Care Med; 2021 Jul; 49(7):1137-1148. PubMed ID: 33710031
[TBL] [Abstract][Full Text] [Related]
7. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation.
Kressin C; Thompson Bastin M; Ather A; Gopinath A; Srour H; Schadler A; Pandya K
J Clin Pharmacol; 2021 Nov; 61(11):1415-1420. PubMed ID: 34180067
[TBL] [Abstract][Full Text] [Related]
8. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
Gallo de Moraes A; El-Yafawi R; Oeckler RA
N Engl J Med; 2019 Aug; 381(8):787. PubMed ID: 31433934
[No Abstract] [Full Text] [Related]
9. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
Aquino Esperanza J; de Haro C; Blanch L
N Engl J Med; 2019 Aug; 381(8):785-786. PubMed ID: 31433932
[No Abstract] [Full Text] [Related]
10. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
Brink M; Everaars N; de Pont AJM
N Engl J Med; 2019 Aug; 381(8):785. PubMed ID: 31433931
[No Abstract] [Full Text] [Related]
11. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. Reply.
Moss M; Ulysse CA; Angus DC;
N Engl J Med; 2019 Aug; 381(8):787-788. PubMed ID: 31433935
[No Abstract] [Full Text] [Related]
12. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.
Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ;
Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular Blocker Use in Critically Ill Children: Assessing Mortality Risk by Propensity Score-Weighted Analysis.
Daverio M; Sperotto F; Stefani C; Mondardini MC; Tessari A; Biban P; Izzo F; Montani C; Lapi M; Picconi E; Racca F; Marinosci GZ; Savron F; Wolfler A; Amigoni A;
Crit Care Med; 2022 Mar; 50(3):e294-e303. PubMed ID: 34582423
[TBL] [Abstract][Full Text] [Related]
14. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
Mefford B; Donaldson JC; Bissell BD
Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
[No Abstract] [Full Text] [Related]
15. Applications of airway pressure release ventilation.
Porhomayon J; El-Solh AA; Nader ND
Lung; 2010 Apr; 188(2):87-96. PubMed ID: 20049471
[TBL] [Abstract][Full Text] [Related]
16. Power Calculations to Select Instruments for Clinical Trial Secondary Endpoints. A Case Study of Instrument Selection for Post-Traumatic Stress Symptoms in Subjects with Acute Respiratory Distress Syndrome.
Sjoding MW; Schoenfeld DA; Brown SM; Hough CL; Yealy DM; Moss M; Angus DC; Iwashyna TJ;
Ann Am Thorac Soc; 2017 Jan; 14(1):110-117. PubMed ID: 27788018
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular blockade management in patients with COVID-19.
Chaves-Cardona H; Hernandez-Torres V; Kiley S; Renew J
Korean J Anesthesiol; 2021 Aug; 74(4):285-292. PubMed ID: 33934595
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of neuromuscular blockade: a comparison of train-of-four and the Campbell diagram.
Baedorf Kassis E; Train S; MacNeil B; Loring SH; Talmor D
Intensive Care Med; 2018 Dec; 44(12):2305-2306. PubMed ID: 30350170
[No Abstract] [Full Text] [Related]
19. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular Blockers in Acute Respiratory Distress Syndrome: Flat Dose or Not. Are We Missing the Point?
Quintin L
Crit Care Med; 2020 May; 48(5):e438. PubMed ID: 32301792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
